Application of Ultrasound E Imaging in the Diagnosis of Non-alcoholic Fatty Liver Disease

doi:10.7517/issn.1674-0475.200318

Abstract

Abstract: To investigate the value of ultrasound E imaging in the diagnosis of non-alcoholic fatty liver disease (NAFLD). 120 patients with non-alcoholic fatty liver were selected as the NAFLD group, and another 50 healthy subjects were selected as the healthy control group. Ultrasound E imaging was performed in both groups. Evaluate the diagnostic value of Young's modulus value to NAFLD and different pathological stages of NAFLD. Young's modulus value of NAFLD group was significantly higher than that of the healthy control group. With the aggravation of pathological stages, the Young's modulus value gradually increased (P<0.05). Young's modulus value has a high differential diagnosis value for NAFLD in different pathology of liver cirrhosis, liver fibrosis, and hepatitis. Enhanced young's modulus in patients with NAFLD can be used for clinical diagnosis of NAFLD and differential diagnosis of different pathological stages.

Key words: ultrasound E-imaging, non-alcoholic fatty liver disease, pathological staging, diagnosis

ZHANG Ran, XU Yicai, LIU Qi, SHI Chaoling, YANG Xiaoqing. Application of Ultrasound E Imaging in the Diagnosis of Non-alcoholic Fatty Liver Disease[J]. Imaging Science and Photochemistry, 2020, 38(5): 828-832.

References

[1] 胡璇,廖献花,叶俊钊,等.磁共振波谱在非酒精性脂肪肝的临床应用和进展[J].肝脏,2017,22(5):464-467.
[2] 朱红梅,王勤英.非酒精性脂肪性肝病肝纤维化的诊断和治疗进展[J].临床肝胆病杂志,2020,36(1):178-181.
[3] 王燕,马燕,吴琦琦,等.非酒精性脂肪性肝病进展性肝纤维化危险因素分析[J].胃肠病学和肝病学杂志,2019,28(1):96-100.
[4] 王晓青,琚坚,胡敏敏,等.非酒精性脂肪肝病治疗的研究进展[J].世界华人消化杂志,2014,22(10):1378-1383.
[5] 李瑾,阎安,崔丽安.脂肪肝防治的研究进展[J].湖南中医杂志,2014,30(3):137-138.
[6] 乐琦琦,刘晏.非酒精性脂肪肝的临床和药理研究进展[J].中成药,2014,36(2):371-376.
[7] 史丽娟,宋光耀.非酒精性脂肪肝中肝脂沉积的机制研究进展[J].生理科学进展,2013,44(6):415-419.
[8] 董姝,刘平,孙明瑜.非酒精性脂肪肝的治疗研究进展[J].辽宁中医杂志,2013,40(3):599-602.
[8] 郭泽淇,王倩怡,祁兴顺,等.《2017年美国肝病学会非酒精性脂肪性肝病诊疗指导》摘译[J].临床肝胆病杂志,2017,33(12):2275-2277.
[9] 张婷.非酒精性脂肪性肝病的治疗策略[J].中国临床医生杂志,2020,48(1):12-15.
[10] 王燕,马燕,吴琦琦,等.非酒精性脂肪性肝病进展性肝纤维化危险因素分析[J].胃肠病学和肝病学杂志,2019,28(1):96-100.
[11] 吴瑞红,张磊,丁艳华,等.非酒精性脂肪性肝病无创诊断研究进展[J].药学进展,2020,44(3):164-178.
[12] 胡玉锋,黄松华.疏肝调脂汤联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝病患者的临床效果[J].中国现代医生,2018,31(17):133-134.
[13] 黄文俊,施钦柔,石安华,等.中医药治疗非酒精性脂肪肝动物模型实验研究进展[J].辽宁中医杂志,2012,39(10):2097-2099.
[14] 刘文娟,王丽华.经颅多普勒超声诊断合并非酒精性脂肪肝的急性脑梗死患者的作用价值分析[J].脑与神经疾病杂志,2019,27(12):744-747.
[15] 张瑛.瞬时弹性成像技术FAI值对非酒精性脂肪肝及其分级诊断的价值[J].影像研究与医学应用,2019,3(10):106-107.
[16] 黄超,胡海华,赵红星,等.定量CT技术在非酒精性脂肪肝定量诊断中的价值分析[J].中国现代医生,2019,57(7):130-132,136.
[17] 周勤娟.彩色多普勒超声诊断非酒精性脂肪肝及其分度的临床价值[J].影像研究与医学应用,2019,3(2):111-112.
[18] 陈萍,程小飞,梁雄波,等.CAP对诊断评估非酒精性脂肪肝的价值[J].中国药物与临床,2018,13(29):53-54.
[19] 陈刚,索方方,陈少武,等.QCT和MR在非酒精性脂肪肝诊断中的应用价值[J].中国CT和MRI杂志,2018,16(8):93-103.
[20] 郑晓,黄文祥,李仁华,等.实时剪切波弹性成像评估非酒精性脂肪性肝病脂肪变程度的应用价值[J].重庆医科大学学报,2019,44(11):1458-1462.
[21] 贺鹏,任波,李玲,等.剪切波弹性成像技术在非酒精性脂肪性肝病诊断及肝纤维化分级中应用的初步研究[J].中国临床医学影像杂志,2017,28(9):637-641.
[22] 庄小芳,孙洁,王晓波,等.瞬时弹性成像技术诊断非酒精性脂肪性肝病的性能评估[J].临床肝胆病杂志,2017,33(12):2366-2371.
[23] 高银杰,孟繁平,赵景民.超声弹性成像技术在非酒精性脂肪肝中的临床应用价值[J].武警医学,2016,27(3):313-316.
[24] 张清华,杨新官,唐艳云.肝纤维化分期诊断中磁共振弹性成像技术的临床应用[J].影像技术,2020,32(3):38-40.